Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

225 related articles for article (PubMed ID: 31742837)

  • 1. New addiction to the NRF2-related factor NRF3 in cancer cells: Ubiquitin-independent proteolysis through the 20S proteasome.
    Kobayashi A; Waku T
    Cancer Sci; 2020 Jan; 111(1):6-14. PubMed ID: 31742837
    [TBL] [Abstract][Full Text] [Related]  

  • 2. NRF3-POMP-20S Proteasome Assembly Axis Promotes Cancer Development via Ubiquitin-Independent Proteolysis of p53 and Retinoblastoma Protein.
    Waku T; Nakamura N; Koji M; Watanabe H; Katoh H; Tatsumi C; Tamura N; Hatanaka A; Hirose S; Katayama H; Tani M; Kubo Y; Hamazaki J; Hamakubo T; Watanabe A; Murata S; Kobayashi A
    Mol Cell Biol; 2020 Apr; 40(10):. PubMed ID: 32123008
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Roles of NRF3 in the Hallmarks of Cancer: Proteasomal Inactivation of Tumor Suppressors.
    Kobayashi A
    Cancers (Basel); 2020 Sep; 12(9):. PubMed ID: 32962187
    [TBL] [Abstract][Full Text] [Related]  

  • 4. β-Catenin/TCF4 Complex-Mediated Induction of the
    Aono S; Hatanaka A; Hatanaka A; Gao Y; Hippo Y; Taketo MM; Waku T; Kobayashi A
    Int J Mol Sci; 2019 Jul; 20(13):. PubMed ID: 31288376
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Pathophysiological Potentials of NRF3-Regulated Transcriptional Axes in Protein and Lipid Homeostasis.
    Waku T; Kobayashi A
    Int J Mol Sci; 2021 Nov; 22(23):. PubMed ID: 34884489
    [TBL] [Abstract][Full Text] [Related]  

  • 6. NFE2L1 and NFE2L3 Complementarily Maintain Basal Proteasome Activity in Cancer Cells through CPEB3-Mediated Translational Repression.
    Waku T; Katayama H; Hiraoka M; Hatanaka A; Nakamura N; Tanaka Y; Tamura N; Watanabe A; Kobayashi A
    Mol Cell Biol; 2020 Jun; 40(14):. PubMed ID: 32366381
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Regulation of the 20S Proteasome by a Novel Family of Inhibitory Proteins.
    Olshina MA; Arkind G; Kumar Deshmukh F; Fainer I; Taranavsky M; Hayat D; Ben-Dor S; Ben-Nissan G; Sharon M
    Antioxid Redox Signal; 2020 Mar; 32(9):636-655. PubMed ID: 31903784
    [No Abstract]   [Full Text] [Related]  

  • 8. Stringent Control of NFE2L3 (Nuclear Factor, Erythroid 2-Like 3; NRF3) Protein Degradation by FBW7 (F-box/WD Repeat-containing Protein 7) and Glycogen Synthase Kinase 3 (GSK3).
    Kannan MB; Dodard-Friedman I; Blank V
    J Biol Chem; 2015 Oct; 290(43):26292-302. PubMed ID: 26306035
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Regulating the 20S proteasome ubiquitin-independent degradation pathway.
    Ben-Nissan G; Sharon M
    Biomolecules; 2014 Sep; 4(3):862-84. PubMed ID: 25250704
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Tetramethylpyrazine Nitrone Promotes the Clearance of Alpha-Synuclein via Nrf2-Mediated Ubiquitin-Proteasome System Activation.
    Guo B; Zheng C; Cao J; Qiu X; Luo F; Li H; Lee SM; Yang X; Zhang G; Sun Y; Zhang Z; Wang Y
    Neuromolecular Med; 2024 Apr; 26(1):9. PubMed ID: 38568291
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Differential and overlapping targets of the transcriptional regulators NRF1, NRF2, and NRF3 in human cells.
    Liu P; Kerins MJ; Tian W; Neupane D; Zhang DD; Ooi A
    J Biol Chem; 2019 Nov; 294(48):18131-18149. PubMed ID: 31628195
    [TBL] [Abstract][Full Text] [Related]  

  • 12. The proteasome and the degradation of oxidized proteins: part III-Redox regulation of the proteasomal system.
    Höhn TJ; Grune T
    Redox Biol; 2014; 2():388-94. PubMed ID: 24563857
    [TBL] [Abstract][Full Text] [Related]  

  • 13. JNK-NQO1 axis drives TAp73-mediated tumor suppression upon oxidative and proteasomal stress.
    Kostecka A; Sznarkowska A; Meller K; Acedo P; Shi Y; Mohammad Sakil HA; Kawiak A; Lion M; Królicka A; Wilhelm M; Inga A; Zawacka-Pankau J
    Cell Death Dis; 2014 Oct; 5(10):e1484. PubMed ID: 25341038
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Multiple regulatory mechanisms of the biological function of NRF3 (NFE2L3) control cancer cell proliferation.
    Chowdhury AMMA; Katoh H; Hatanaka A; Iwanari H; Nakamura N; Hamakubo T; Natsume T; Waku T; Kobayashi A
    Sci Rep; 2017 Oct; 7(1):12494. PubMed ID: 28970512
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Complexity of CNC transcription factors as revealed by gene targeting of the Nrf3 locus.
    Derjuga A; Gourley TS; Holm TM; Heng HH; Shivdasani RA; Ahmed R; Andrews NC; Blank V
    Mol Cell Biol; 2004 Apr; 24(8):3286-94. PubMed ID: 15060151
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Nrf3 promotes UV-induced keratinocyte apoptosis through suppression of cell adhesion.
    Siegenthaler B; Defila C; Muzumdar S; Beer HD; Meyer M; Tanner S; Bloch W; Blank V; Schäfer M; Werner S
    Cell Death Differ; 2018 Nov; 25(10):1749-1765. PubMed ID: 29487353
    [TBL] [Abstract][Full Text] [Related]  

  • 17. NF-kappaB mediates proteolysis-inducing factor induced protein degradation and expression of the ubiquitin-proteasome system in skeletal muscle.
    Wyke SM; Tisdale MJ
    Br J Cancer; 2005 Feb; 92(4):711-21. PubMed ID: 15714207
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Degradation of oxidized proteins by the proteasome: Distinguishing between the 20S, 26S, and immunoproteasome proteolytic pathways.
    Raynes R; Pomatto LC; Davies KJ
    Mol Aspects Med; 2016 Aug; 50():41-55. PubMed ID: 27155164
    [TBL] [Abstract][Full Text] [Related]  

  • 19. TCF11 at the crossroads of oxidative stress and the ubiquitin proteasome system.
    Koch A; Steffen J; Krüger E
    Cell Cycle; 2011 Apr; 10(8):1200-7. PubMed ID: 21412055
    [TBL] [Abstract][Full Text] [Related]  

  • 20. NFE2L3 drives hepatocellular carcinoma cell proliferation by regulating the proteasome-dependent degradation of ISGylated p53.
    Ren Y; Yang J; Ding Z; Zheng M; Qiu L; Tang A; Huang D
    Cancer Sci; 2023 Sep; 114(9):3523-3536. PubMed ID: 37350063
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 12.